Systemic Inflammatory Reaction in Patients With Head and Neck Cancer-An Explorative Study [Elektronisk resurs]

Astradsson, Thorsteinn (författare)

Sellberg, Felix (författare)

Berglund, David, 1984- (författare)

Tiblom Ehrsson, Ylva (författare)

Laurell, Göran (författare)

Uppsala universitet Medicinska och farmaceutiska vetenskapsområdet (utgivare)

Publicerad: FRONTIERS MEDIA SA, 2019
Engelska.
Ingår i: Frontiers in Oncology. - 2234-943X. ; 9

Läs hela texten

E-artikel/E-kapitel

Sammanfattning Ämnesord

Stäng

Aim: To assess the longitudinal pattern of pro-inflammatory cytokines and growth factors in serum up to 1 year following treatment for head and neck cancer. Materials and Methods: Patients with newly diagnosed, curable head and neck cancer were included (n = 30). The most common subsite was oropharynx (n = 13) followed by oral cavity (n = 9). Blood was drawn from all patients at regular intervals (before treatment, 7 weeks after the start of the treatment, and at 3 months and 1 year after termination of treatment) and analyzed for cytokines (Il-1 beta, Il-2, Il-4, Il-5, Il-6, Il-8, Il-10, GM-CSF, TNF-alpha, and IFN-gamma) and growth factors (G-CSF, FGF-2, EGF, and VEGF). Results: The time point of the peak level of pro-inflammatory cytokines was 7 weeks after start of treatment which corresponded for the majority of patients with termination of radiotherapy or chemoradiotherapy. Patients undergoing chemoradiotherapy exhibited a significant increase of IL-1 beta, IL-6, and IL-10 at 7 weeks as compared to pre-treatment levels. At 1 year after termination of treatment four patients experienced recurrence of disease while 26 patients were considered disease-free. The patients with recurrence had significantly higher levels of IL-1 beta, IL-6, IL-8, and IL-10 at 7 weeks after the start of treatment than patients without recurrence. Correlated with T stadium patients with T3-T4 had higher levels of IL-1 beta and IL-8 than patients with T1-T2 7 weeks after the start of treatment. Conclusions: The observed immune response in this explorative study demonstrates that chemoradiotherapy may induce not only a local treatment effect on the immune system but also effects far outside the irradiated field. The result of the study indicates that analysis of a pro-inflammatory panel of cytokines in serum at 7 weeks after the start of treatment could be of prognostic value in patients with head and neck cancer. Further study of a larger cohort could help identify patients at larger risk for recurrent disease with measurements of pro-inflammatory cytokines under and after treatment.

Länka till posten

Inställningar Hjälp

Beståndsinformation saknas

1 av 1
Föregående post
Nästa post
Till träfflistan

Sök vidare

Hjälp

Fler titlar av: Astradsson, Thorstei ...; Sellberg, Felix; Berglund, David, 198 ...; Tiblom Ehrsson, Ylva; Laurell, Göran; Uppsala universitet ...; visa fler...; visa färre...
Fler titlar om: Medical and Health S ...; Clinical Medicine; Cancer and Oncology; Medicin och hälsovet ...; Klinisk medicin; Cancer och onkologi
Fler titlar i denna genre: government publicati ...
Värdpublikation: Frontiers in Oncolog ...; Fler artiklar

Sök utanför LIBRIS

Hjälp

Sök vidare i:: Google; Google Book Search; Google Scholar; LibraryThing

Om LIBRIS: Sekretess

Hjälp: Fel i posten?; Kontakt; Teknik och format

Sök utifrån: Sökrutor; Plug-ins; Bookmarklet

Anpassa: Textstorlek; Kontrast; Vyer

LIBRIS söktjänster: SwePub; Uppsök

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Systemic Inflammatory Reaction in Patients With Head and Neck Cancer-An Explorative Study [Elektronisk resurs]

Ämnesord

Genre

Indexterm och SAB-rubrik

Sök vidare

Sök utanför LIBRIS